Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 48,854 shares at $18.58 ($886K) on 2022-11-07, disclosed to the SEC on 2022-11-09.
Open-market sale of $886k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.79 | 11,122 | $198K | 22.3% |
| 2 | $17.79 | 11,122 | $198K | 22.3% |
| 3 | $18.58 | 3,359 | $62K | 7.0% |
| 4 | $18.58 | 3,359 | $62K | 7.0% |
| 5 | $19.57 | 1,486 | $29K | 3.3% |
| 6 | $20.24 | 1,660 |
| $34K |
| 3.8% |
| 7 | $18.09 | 8,373 | $151K | 17.1% |
| 8 | $18.09 | 8,373 | $151K | 17.1% |
| Total | $18.14 avg | 48,854 | $886K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |